Department of Obstetrics and Gynaecology

Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. (2022) Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, Mccluggage WG, Pöschke P, et al. Journal article The COVID-19 pandemic and its impact on medical teaching in obstetrics and gynecology-A nationwide expert survey among teaching coordinators at German university hospitals (2022) Riedel M, Amann N, Recker F, Hennigs A, Heublein S, Meyer B, Karge A, et al. Journal article Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT (2022) Engler T, Fasching P, Lueftner D, Hartkopf AD, Mueller V, Kolberg HC, Hadji P, et al. Journal article Update S3-Leitlinie Zervixkarzinom: Diagnostik, Therapie und Nachsorge (2022) Stübs F, Beckmann M, Fehm T Journal article Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy (2022) Schneider M, Pretscher J, Goecke T, Häberle L, Engel A, Kornhuber J, Eichler A, et al. Journal article Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients with Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial (2022) Blohmer JU, Link T, Reinisch M, Just M, Untch M, Stotzer O, Fasching P, et al. Journal article Superpixel Pre-segmentation of HER2 Slides for Efficient Annotation (2022) Öttl M, Mönius J, Marzahl C, Rübner M, Geppert CI, Hartmann A, Beckmann M, et al. Conference contribution, Conference Contribution Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial (2022) Graf J, Sickenberger N, Brusniak K, Matthies LM, Deutsch TM, Simoes E, Plappert C, et al. Journal article Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study (2022) Woelber L, Hampl M, Eulenburg CZ, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Journal article Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial (2022) Jerusalem G, Delea TE, Martin M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Journal article